0001699688-21-000002.txt : 20211019 0001699688-21-000002.hdr.sgml : 20211019 20211019121424 ACCESSION NUMBER: 0001699688-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211019 DATE AS OF CHANGE: 20211019 EFFECTIVENESS DATE: 20211019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envisagenics, Inc. CENTRAL INDEX KEY: 0001699688 IRS NUMBER: 465496412 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-417537 FILM NUMBER: 211330131 BUSINESS ADDRESS: STREET 1: 101 6TH AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 929-777-2001 MAIL ADDRESS: STREET 1: 101 6TH AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0001699688 Envisagenics, Inc. 101 6TH AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10013 929-777-2001 DELAWARE None None Corporation true MARIA LUISA PINEDA C/O ENVISAGENICS, INC. 101 6TH AVENUE, 3RD FLOOR NEW YORK NY NEW YORK 10013 Executive Officer Director CEO MARTIN AKERMAN C/O ENVISAGENICS, INC. 101 6TH AVENUE, 3RD FLOOR NEW YORK NY NEW YORK 10013 Executive Officer Director CTO GRANT VERSTANDING 345 NORTH MAPLE DRIVE SUITE 175 BEVERLY HILLS CA CALIFORNIA 90210 Director ALAN S. ROEMER C/O ENVISAGENICS, INC. 101 6TH AVENUE, 3RD FLOOR NEW YORK NY NEW YORK 10013 Director BRADLEY HARRIS C/O ENVISAGENICS, INC. 101 6TH AVENUE, 3RD FLOOR NEW YORK NY NEW YORK 10013 Executive Officer Secretary Biotechnology Decline to Disclose 06b false 2021-09-22 false true false 1 19181626 19181626 0 This filing covers the sale and issuance of Series A-4 Preferred Stock, the conversion of certain convertible promissory notes into Series A-1, A-2 and A-3 Preferred Stock and the Common Stock issuable upon conversion of such Preferred Stock. false 24 0 0 0 false Envisagenics, Inc. /s/ Maria Luisa Pineda Maria Luisa Pineda Chief Executive Officer 2021-10-08